Literature DB >> 22908198

PlGF: a multitasking cytokine with disease-restricted activity.

Mieke Dewerchin1, Peter Carmeliet.   

Abstract

Placental growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family that also comprises VEGF-A (VEGF), VEGF-B, VEGF-C, and VEGF-D. Unlike VEGF, PlGF is dispensable for development and health but has diverse nonredundant roles in tissue ischemia, malignancy, inflammation, and multiple other diseases. Genetic and pharmacological gain-of-function and loss-of-function studies have identified molecular mechanisms of this multitasking cytokine and characterized the therapeutic potential of delivering or blocking PlGF for various disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908198      PMCID: PMC3405829          DOI: 10.1101/cshperspect.a011056

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  183 in total

1.  Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy.

Authors:  Jenny Yao; Xiumin Wu; Guanglei Zhuang; Ian M Kasman; Tobias Vogt; Vernon Phan; Masabumi Shibuya; Napoleone Ferrara; Carlos Bais
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

2.  Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia.

Authors:  Thomas Schmidt; Behzad Kharabi Masouleh; Sonja Loges; Sandra Cauwenberghs; Peter Fraisl; Christa Maes; Bart Jonckx; Kim De Keersmaecker; Maria Kleppe; Marc Tjwa; Thomas Schenk; Stefan Vinckier; Rita Fragoso; Maria De Mol; Karolien Beel; Sérgio Dias; Catherine Verfaillie; Richard E Clark; Tim H Brümmendorf; Peter Vandenberghe; Shahin Rafii; Tessa Holyoake; Andreas Hochhaus; Jan Cools; Michael Karin; Geert Carmeliet; Mieke Dewerchin; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

3.  Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection.

Authors:  Xinguo Jiang; Mohammad A Khan; Wen Tian; Joshua Beilke; Ramesh Natarajan; Jon Kosek; Mervin C Yoder; Gregg L Semenza; Mark R Nicolls
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

4.  PlGF gene knockdown in human retinal pigment epithelial cells.

Authors:  Hassan Akrami; Zahra-Soheila Soheili; Majid Sadeghizadeh; Hamid Ahmadieh; Mozhgan Rezaeikanavi; Shahram Samiei; Keynoush Khalooghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

Review 5.  Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis.

Authors:  Masaubmi Shibuya
Journal:  Angiogenesis       Date:  2006-11-16       Impact factor: 9.596

6.  Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors.

Authors:  Julien Laurent; Eveline Faes-van't Hull; Cedric Touvrey; François Kuonen; Qiang Lan; Girieca Lorusso; Marie-Agnès Doucey; Laura Ciarloni; Natsuko Imaizumi; Gian Carlo Alghisi; Ernesta Fagiani; Khalil Zaman; Roger Stupp; Masabumi Shibuya; Jean-François Delaloye; Gerhard Christofori; Curzio Ruegg
Journal:  Cancer Res       Date:  2011-04-20       Impact factor: 12.701

7.  Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

Authors:  Francesca Cianfarani; Giovanna Zambruno; Laura Brogelli; Francesco Sera; Pedro Miguel Lacal; Maurizio Pesce; Maurizio C Capogrossi; Cristina Maria Failla; Monica Napolitano; Teresa Odorisio
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

8.  Impaired adipose tissue development in mice with inactivation of placental growth factor function.

Authors:  H Roger Lijnen; Valerie Christiaens; Ilse Scroyen; Gabor Voros; Marc Tjwa; Peter Carmeliet; Désiré Collen
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

9.  Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy.

Authors:  Stephen Kolakowski; Mark F Berry; Pavan Atluri; Todd Grand; Omar Fisher; M Astrid Moise; Jeffrey Cohen; Vivian Hsu; Y Joseph Woo
Journal:  J Card Surg       Date:  2006 Nov-Dec       Impact factor: 1.620

10.  Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.

Authors:  Hu Huang; Jikui Shen; Stanley A Vinores
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

View more
  89 in total

1.  PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Authors:  Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby
Journal:  Am J Reprod Immunol       Date:  2017-06-20       Impact factor: 3.886

2.  PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity.

Authors:  Joao Incio; Josh Tam; Nuh N Rahbari; Priya Suboj; Dan T McManus; Shan M Chin; Trupti D Vardam; Ana Batista; Suboj Babykutty; Keehoon Jung; Anna Khachatryan; Tai Hato; Jennifer A Ligibel; Ian E Krop; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Masabumi Shibuya; Peter Carmeliet; Raquel Soares; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Clin Cancer Res       Date:  2016-02-09       Impact factor: 12.531

Review 3.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

4.  Elastase induces lung epithelial cell autophagy through placental growth factor: a new insight of emphysema pathogenesis.

Authors:  Hsin-Han Hou; Shih-Lung Cheng; Kuei-Pin Chung; Mark Yen-Ping Kuo; Cheng-Chang Yeh; Bei-En Chang; Hsuan-Hsuan Lu; Hao-Chien Wang; Chong-Jen Yu
Journal:  Autophagy       Date:  2014-06-25       Impact factor: 16.016

Review 5.  The cerebral circulation during pregnancy: adapting to preserve normalcy.

Authors:  Abbie C Johnson; Marilyn J Cipolla
Journal:  Physiology (Bethesda)       Date:  2015-03

Review 6.  Chronic allograft rejection: a fresh look.

Authors:  Johannes Wedel; Sarah Bruneau; Nora Kochupurakkal; Leo Boneschansker; David M Briscoe
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

Review 7.  Clinical pharmacology of intravitreal anti-VEGF drugs.

Authors:  Stefano Fogli; Marzia Del Re; Eleonora Rofi; Chiara Posarelli; Michele Figus; Romano Danesi
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

8.  Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression.

Authors:  Chen Li; Yu Zhou; Anastacia Loberg; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Mol Cell Biol       Date:  2016-10-28       Impact factor: 4.272

9.  Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.

Authors:  H R Nejabati; A Mota; L Farzadi; M Ghojazadeh; A Fattahi; K Hamdi; M Nouri
Journal:  J Endocrinol Invest       Date:  2016-09-23       Impact factor: 4.256

10.  Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.

Authors:  Matija Snuderl; Ana Batista; Nathaniel D Kirkpatrick; Carmen Ruiz de Almodovar; Lars Riedemann; Elisa C Walsh; Rachel Anolik; Yuhui Huang; John D Martin; Walid Kamoun; Ellen Knevels; Thomas Schmidt; Christian T Farrar; Benjamin J Vakoc; Nishant Mohan; Euiheon Chung; Sylvie Roberge; Teresa Peterson; Carlos Bais; Boryana H Zhelyazkova; Stephen Yip; Martin Hasselblatt; Claudia Rossig; Elisabeth Niemeyer; Napoleone Ferrara; Michael Klagsbrun; Dan G Duda; Dai Fukumura; Lei Xu; Peter Carmeliet; Rakesh K Jain
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.